What are the treatment options for eczema?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Eczema

Topical corticosteroids are the first-line treatment for eczema, with potency selection based on severity, and should be used for short periods (2-4 weeks) to avoid side effects such as skin atrophy. 1

First-Line Treatments

Topical Corticosteroids (TCS)

  • Potency selection based on severity:
    • High-potency: For acute flares
    • Medium-potency: For longer treatments
    • Low-potency: For mild cases and sensitive areas (face, genitals, skin folds)
  • Application frequency: Once daily application is as effective as twice daily for potent corticosteroids 2, 3
  • Duration: Short periods (2-4 weeks) to avoid side effects 1
  • Risk of skin thinning: Low with short-term use (1-16 weeks), but increases with longer-term use (6-60 months) 3

Emollients

  • Application: Apply liberally and frequently (3-8 times daily)
  • Characteristics: Should be fragrance-free
  • Timing: Apply immediately after bathing to trap moisture
  • Continued use: Use even when skin appears normal 1

Second-Line Treatments

Topical Calcineurin Inhibitors (TCIs)

  • Indications: For patients ≥2 years old who are unresponsive to or intolerant of topical corticosteroids 1
  • Options:
    • Tacrolimus 0.1%: Highly effective, similar to potent TCS 3
    • Tacrolimus 0.03%: For milder cases
    • Pimecrolimus 1% (Elidel): For sensitive areas
  • Application: Thin layer to affected areas twice daily until lesions clear 1
  • Safety note: Should not be used continuously for long periods due to theoretical cancer risk 4
  • Side effects: More likely to cause application site reactions than TCS 3

Newer Topical Agents

  • JAK inhibitors (e.g., ruxolitinib 1.5%, delgocitinib 0.5%): Highly effective, similar to potent TCS 3
  • PDE-4 inhibitors (e.g., crisaborole 2%, roflumilast): Less effective than TCS and TCIs 3

Prevention of Flares

Proactive (Weekend) Therapy

  • Approach: Apply topical anti-inflammatories twice weekly to previously affected areas even when clear
  • Effectiveness: Reduces likelihood of relapse from 58% to 25% 2
  • Duration: Can be used long-term with breaks in between treatments 1, 5

Infection Management

  • Clinically evident infections: Treat with appropriate antibiotics
  • Prevention: Consider bleach baths with 0.005% sodium hypochlorite twice weekly 1
  • For erosive lesions: Consider antiseptic washes with aqueous chlorhexidine 0.05% 1

Systemic Treatments for Moderate-to-Severe Eczema

When to Consider Systemic Therapy

  • Inadequate response to optimized topical therapy
  • Severe, widespread disease
  • Significant impact on quality of life

Options

  • Biologics: Dupilumab
  • JAK inhibitors: Abrocitinib, baricitinib, upadacitinib
  • Traditional immunomodulators: Cyclosporine, methotrexate, azathioprine, mycophenolate mofetil
  • Short-term oral corticosteroids: Prednisone (1 mg/kg/day) with tapering over at least 4 weeks 1

Additional Therapies

  • Phototherapy: Consider referral for phototherapy (oral PUVA) for chronic or recurrent cases 1
  • Patch testing: Consider for patients with persistent or recalcitrant atopic dermatitis 1

Common Pitfalls to Avoid

  • Overuse of topical corticosteroids: Can lead to skin atrophy, telangiectasias, and striae
  • Undertreatment: Using too weak a potency for the severity of eczema
  • Inappropriate use of antibiotics: Only use for clinically evident infections, not for prevention 5
  • Reliance on antihistamines: Little evidence supports their continued use for eczema 5
  • Use of unproven therapies: Silk clothing, ion-exchange water softeners, and emollient bath additives have not been shown to benefit eczema patients 5

When to Refer to a Specialist

  • Diagnostic uncertainty
  • Poor response to initial treatment
  • Suspicion of autoimmune skin disease
  • Need for skin biopsy
  • Severe or widespread disease requiring systemic therapy 1

References

Guideline

Treatment of Atopic Dermatitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Strategies for using topical corticosteroids in children and adults with eczema.

The Cochrane database of systematic reviews, 2022

Research

Topical anti-inflammatory treatments for eczema: network meta-analysis.

The Cochrane database of systematic reviews, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.